NASDAQ RESUMED
NASDAQ RESUMED ARYA.O
Recent news on Immatics
See all newsImmatics up after deal with Moderna to develop cancer vaccines
U.S. RESEARCH ROUNDUP- Agrify, Okta, Schnitzer Steel Industries
Brief: Immatics NV Says Company Projects A Cash Runway Into 2024
Bristol Myers enters up to $920 mln deal with Immatics for cancer drug
Brief: Immatics And Bristol Myers Squibb Enter Into Global Exclusive License For Immatics’ TCR Bispecific Program Ima401